Evidence map›Paper›PMID 32796656›Full record

ArticleMolecules (Basel, Switzerland)2020

Characterizing Epitope Binding Regions of Entire Antibody Panels by Combining Experimental and Computational Analysis of Antibody: Antigen Binding Competition.

Benjamin D Brooks, Adam Closmore, Juechen Yang, Michael Holland, Tina Cairns, Gary H Cohen, Chris Bailey-Kellogg

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Recent Progress in Antibody Epitope Prediction.Antibodies (Basel, Switzerland) · 2023
    Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Benjamin D BrooksDepartment of Biomedical Sciences, Rocky Vista University, Ivins, UT 84738, USA.ORCID 0000-0001-7456-3074
Adam ClosmoreDepartment of Pharmacy, North Dakota State University, Fargo, ND 58102, USA.
Juechen YangDepartment of Biomedical Engineering, North Dakota State University, Fargo, ND 58102, USA.
Michael HollandDepartment of Biomedical Engineering, North Dakota State University, Fargo, ND 58102, USA.
Tina CairnsDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Gary H CohenDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Chris Bailey-KelloggComputer Science Department, Dartmouth, Hanover, NH 03755, USA.

Funding

Studies of Herpes Simplex Virus GlycoproteinsR37AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 2005 to 2014
$3.9M
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINSR01AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 1985 to 2019
$3.8M
High-throughput, multiplexed characterization and modeling of antibody:antigen binding, with application to HSVR43AI132075 · NIAID · CARTERRA, INC. · PI BAILEY-KELLOGG, CHRIS, BROOKS, BENJAMIN DELBERT · 2017 to 2017
$300k
Improving HSV-2 vaccine efficacy by focusing antibody epitope coverage.R41AI142940 · NIAID · STEALTH BIOLOGICS, LLC · PI BAILEY-KELLOGG, CHRIS, BROOKS, BENJAMIN DELBERT · 2019 to 2019
$285k
National Institute of Allergy and Infectious Diseases 1R43AI132075-01NIAID NIH HHS R01 AI018289NIAID NIH HHS R37 AI018289NIAID NIH HHS R41 AI142940NIH HHS 1R43AI132075-01
6 · The paper itself

Abstract

Vaccines and immunotherapies depend on the ability of antibodies to sensitively and specifically recognize particular antigens and specific epitopes on those antigens. As such, detailed characterization of antibody-antigen binding provides important information to guide development. Due to the time and expense required, high-resolution structural characterization techniques are typically used sparingly and late in a development process. Here, we show that antibody-antigen binding can be characterized early in a process for whole panels of antibodies by combining experimental and computational analyses of competition between monoclonal antibodies for binding to an antigen. Experimental "epitope binning" of monoclonal antibodies uses high-throughput surface plasmon resonance to reveal which antibodies compete, while a new complementary computational analysis that we call "dock binning" evaluates antibody-antigen docking models to identify why and where they might compete, in terms of possible binding sites on the antigen. Experimental and computational characterization of the identified antigenic hotspots then enables the refinement of the competitors and their associated epitope binding regions on the antigen. While not performed at atomic resolution, this approach allows for the group-level identification of functionally related monoclonal antibodies (i.e., communities) and identification of their general binding regions on the antigen. By leveraging extensive epitope characterization data that can be readily generated both experimentally and computationally, researchers can gain broad insights into the basis for antibody-antigen recognition in wide-ranging vaccine and immunotherapy discovery and development programs.

Indexed as

Antibodies, MonoclonalAntigens, ViralBinding, CompetitiveEpitope MappingEpitopesHerpes Simplex Virus VaccinesHerpesvirus 1, HumanHigh-Throughput Screening AssaysHumansProtein ConformationViral Envelope ProteinsAntibodies, MonoclonalAntigens, ViralEpitopesHerpes Simplex Virus VaccinesViral Envelope Proteinsantibody:antigen interactionsepitope binningepitope mappingepitope predictionglycoprotein D (gD)herpes simplex virus fusion proteinsprotein docking

Identifiers

PMID32796656
PMCPMC7464469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.